Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGAM | O43451 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | SI | P14410 | 1/20 | 0.46 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.43 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.39 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.39 |
| ▸ | CA12 | O43570 | 1/20 | 0.38 |
| ▸ | CA1 | P00915 | 1/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | CA9 | Q16790 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5477958 | 1.00 | MGAM (0.46) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL5483236 | 1.00 | MGAM (0.46) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL9174242 | 0.98 | MGAM (0.44) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL30503881 | 0.92 | MGAM (0.45) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL21551850 | 0.91 | GPR84 (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL21551881 | 0.91 | GPR84 (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL21551852 | 0.91 | GPR84 (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL22462113 | 0.88 | GPR84 (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL3676004 | 0.88 | GPR84 (0.50) | MGAMGAASIMGAM2ALDH1A1 | |
| SCHEMBL3676008 | 0.88 | GPR84 (0.50) | MGAMGAASIMGAM2ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 666 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4711010-A2 | PRO-PERFUME COMPOSITIONS | Firmenich SA (CH) | 2026-03-18 | — | — | EP | claimed |
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | DANSTAR FERMENT AG (CH) | 2026-01-29 | — | — | US | claimed |
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | GLYCOSCIENCE, S.L. (ES) | 2025-12-30 | — | — | US | claimed |
| US-20250344991-A1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-11-13 | — | — | US | claimed |
| EP-4635407-A2 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | The Rockefeller University (US) | 2025-10-22 | — | — | EP | claimed |
| EP-3648613-B1 | COMPOSITIONS AND METHODS FOR A UNIVERSAL CLINICAL TEST FOR OLFACTORY DYSFUNCTION | UNIV ROCKEFELLER (US) | 2025-09-24 | — | — | EP | claimed |
| EP-4175486-B1 | COMPOSITION COMPRISING AN OIL PHASE AND AN AQUEOUS PHASE | GIVAUDAN SA (CH) | 2025-08-27 | — | — | EP | claimed |
| US-12398341-B2 | Apparatus and compositions for improving scent delivery | THE PROCTER & GAMBLE COMPANY (US) | 2025-08-26 | — | — | US | claimed |
| EP-4557970-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | Danstar Ferment AG (CH) | 2025-05-28 | — | — | EP | claimed |
| CN-115427421-B | 3' -Ketoglycoside compounds for slow release of volatile alcohols | 格莱克科学有限公司 | 2025-04-01 | — | — | CN | claimed |
| WO-1993022941-A1 | FRESH-LIKE STORAGE-STABLE PULP AND IMPROVED JUICE PRODUCTS AND PROCESS | THE PROCTER & GAMBLE COMPANY (US) | 1993-11-25 | — | — | WO | claimed |
| US-5260086-A | Citrus fruit | THE PROCTER & GAMBLE COMPANY (US) | 1993-11-09 | — | — | US | claimed |
| EP-0292047-B1 | COMMERCIALLY PROCESSED ORANGE JUICE PRODUCTS HAVING A MORE HAND-SQUEEZED CHARACTER | THE PROCTER & GAMBLE COMPANY (US) | 1993-09-08 | — | — | EP | claimed |
| EP-0292048-B1 | METHOD FOR OBTAINING COMMERCIAL FEED JUICES HAVING A MORE HAND-SQUEEZED CHARACTER | CARGILL, INCORPORATED (US) | 1993-07-28 | — | — | EP | claimed |
| US-4938985-A | Commercially processed orange juice products having a more hand-squeezed character | THE PROCTER & GAMBLE COMPANY (US) | 1990-07-03 | — | — | US | claimed |
| EP-0357130-A2 | Process for making shelf-stable orange-juice containing beverages | THE PROCTER & GAMBLE COMPANY (US) | 1990-03-07 | — | — | EP | claimed |
| US-4889739-A | GENTLE EXTRACTION, REMOVAL OF PULP | THE PROCTER & GAMBLE COMPANY (US) | 1989-12-26 | — | — | US | claimed |
| US-4818555-A | PREHEATING; VACUUM HEATING WITH SURFACE SHEARING; RAPID COOLING | THE PROCTER & GAMBLE COMPANY (US) | 1989-04-04 | — | — | US | claimed |
| EP-0292047-A2 | Commercially processed orange juice products having a more hand-squeezed character | THE PROCTER & GAMBLE COMPANY (US) | 1988-11-23 | — | — | EP | claimed |
| EP-0292048-A2 | Method for obtaining commercial feed juices having a more hand-squeezed character | CARGILL, INCORPORATED (US) | 1988-11-23 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12509482-B2 | 3′-ketoglycoside compound for the slow release of a volatile alcohol | EBP, MGAT1, MGAT3 | MGAM 130/4885GAA 1214/4885SI 734/4885 |
| US-20260028562-A1 | FLAVORED POROUS MATERIAL FOR FLAVORED BEVERAGE PRODUCTION | CD69, SORD, TAS2R13 | MGAM 182/4885GAA 265/4885SI 707/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.